Genomic alterations indicative of a luminal A subtype associate with clinical benefit to buparlisib and letrozole in endocrine-resistant ER+/HER2- metastatic breast cancer Meeting Abstract
| Authors: | Balko, J. M.; Hicks, M.; Berger, M. F.; Solit, D. B.; Bouvier, N.; Sanders, M. E.; Estrada, M. V.; Won, H.; Cantley, L. C.; Mayer, I. A.; Arteaga, C. L. |
| Abstract Title: | Genomic alterations indicative of a luminal A subtype associate with clinical benefit to buparlisib and letrozole in endocrine-resistant ER+/HER2- metastatic breast cancer |
| Meeting Title: | 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 76 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2015 Dec 8-12 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2016-02-15 |
| Language: | English |
| ACCESSION: | WOS:000375622400108 |
| DOI: | 10.1158/1538-7445.sabcs15-p3-07-41 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P3-07-41 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
